157 related articles for article (PubMed ID: 24566388)
1. The essential role of TNIK gene amplification in gastric cancer growth.
Yu DH; Zhang X; Wang H; Zhang L; Chen H; Hu M; Dong Z; Zhu G; Qian Z; Fan J; Su X; Xu Y; Zheng L; Dong H; Yin X; Ji Q; Ji J
Oncogenesis; 2014 Feb; 2(2):e89. PubMed ID: 24566388
[TBL] [Abstract][Full Text] [Related]
2. TNIK's emerging role in cancer, metabolism, and age-related diseases.
Ewald CY; Pulous FE; Lok SWY; Pun FW; Aliper A; Ren F; Zhavoronkov A
Trends Pharmacol Sci; 2024 Jun; 45(6):478-489. PubMed ID: 38777670
[TBL] [Abstract][Full Text] [Related]
3. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
4. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma.
Sekita T; Yamada T; Kobayashi E; Yoshida A; Hirozane T; Kawai A; Uno Y; Moriyama H; Sawa M; Nagakawa Y; Tsuchida A; Matsumoto M; Nakamura M; Nakayama R; Masuda M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429395
[TBL] [Abstract][Full Text] [Related]
6. TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton.
Fu CA; Shen M; Huang BC; Lasaga J; Payan DG; Luo Y
J Biol Chem; 1999 Oct; 274(43):30729-37. PubMed ID: 10521462
[TBL] [Abstract][Full Text] [Related]
7. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
8. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
9. TNIK inhibition abrogates colorectal cancer stemness.
Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
11. Enormous influence of TNIK knockdown on intracellular signals and cell survival.
Gui J; Yang B; Wu J; Zhou X
Hum Cell; 2011 Sep; 24(3):121-6. PubMed ID: 21710359
[TBL] [Abstract][Full Text] [Related]
12. The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton.
Taira K; Umikawa M; Takei K; Myagmar BE; Shinzato M; Machida N; Uezato H; Nonaka S; Kariya K
J Biol Chem; 2004 Nov; 279(47):49488-96. PubMed ID: 15342639
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
Lee RS; Zhang L; Berger A; Lawrence MG; Song J; Niranjan B; Davies RG; Lister NL; Sandhu SK; Rubin MA; Risbridger GP; Taylor RA; Rickman DS; Horvath LG; Daly RJ
Neoplasia; 2019 Apr; 21(4):389-400. PubMed ID: 30901730
[TBL] [Abstract][Full Text] [Related]
14. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
15. Identification of Phosphorylation Consensus Sequences and Endogenous Neuronal Substrates of the Psychiatric Risk Kinase TNIK.
Wang Q; Amato SP; Rubitski DM; Hayward MM; Kormos BL; Verhoest PR; Xu L; Brandon NJ; Ehlers MD
J Pharmacol Exp Ther; 2016 Feb; 356(2):410-23. PubMed ID: 26645429
[TBL] [Abstract][Full Text] [Related]
16. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of germinal center kinase TRAF2 and NCK-interacting kinase (TNIK) in B cells does not affect atherosclerosis.
van Os BW; Kusters PJH; den Toom M; Beckers L; van Tiel CM; Vos WG; de Jong E; Kieser A; van Roomen C; Binder CJ; Reiche ME; de Winther MP; Bosmans LA; Lutgens E
Front Cardiovasc Med; 2023; 10():1171764. PubMed ID: 37215541
[TBL] [Abstract][Full Text] [Related]
19. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
[TBL] [Abstract][Full Text] [Related]
20. Fragment growth-based discovery of novel TNIK inhibitors for the treatment of colorectal cancer.
Teng Y; Wu R; Bo W; Tang M; Wang T; Cui X; Li Y; Zhang C; Ma Z; Fu Z; Xu Q; Liu J; Chen L
Eur J Med Chem; 2024 Mar; 268():116240. PubMed ID: 38422698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
